These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38332395)

  • 1. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
    Khanafer NL; Fitzpatrick F; Barbut F; Krutova M; Davies K; Guery B; Vanhems P
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):785-789. PubMed ID: 38332395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
    Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
    BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurses' knowledge, practices and perceptions regarding Clostridioides difficile: Survey results.
    Finnimore K; Smyth W; Carrucan J; Nagle C
    Infect Dis Health; 2023 Feb; 28(1):39-46. PubMed ID: 36002370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of environmental cleaning bundles on reducing healthcare-associated Clostridioides difficile infection: a systematic review and meta-analysis.
    Chau JPC; Liu X; Lo SHS; Chien WT; Wan X
    J Hosp Infect; 2020 Dec; 106(4):734-744. PubMed ID: 32861741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.
    Toth DJA; Keegan LT; Samore MH; Khader K; O'Hagan JJ; Yu H; Quintana A; Swerdlow DL
    Vaccine; 2020 Aug; 38(37):5927-5932. PubMed ID: 32703744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Visitor Contact Precautions With Estimated Hospital-Onset Clostridioides difficile Infection Rates in Acute Care Hospitals.
    Scaria E; Barker AK; Alagoz O; Safdar N
    JAMA Netw Open; 2021 Feb; 4(2):e210361. PubMed ID: 33635330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of no-touch ultraviolet light room disinfection systems on Clostridioides difficile infections.
    McMullen K; Guth RM; Wood H; Mueller C; Dunn G; Wade R; Siddiqui A; Dubberke ER; Woeltje KF; Warren DK
    Am J Infect Control; 2021 May; 49(5):646-648. PubMed ID: 32860846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset
    Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontline perspectives of C. difficile infection prevention practice implementation within veterans affairs health care facilities: A qualitative study.
    Parmasad V; Keating J; McKinley L; Evans C; Rubin M; Voils C; Safdar N
    Am J Infect Control; 2023 Oct; 51(10):1124-1131. PubMed ID: 36977453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of prevention practices with rates of health care-associated
    Musuuza JS; McKinley L; Keating JA; Obasi C; Knobloch MJ; Crnich C; Evans CT; Evans ME; Livorsi D; Morgan DJ; Perencevich EN; Reisinger HS; Schweizer ML; Suda KJ; Simbartl LA; Safdar N
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):52-58. PubMed ID: 31658933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
    Viprey VF; Granata G; Vendrik KEW; Davis GL; Petrosillo N; Kuijper EJ; Vilken T; Lammens C; Schotsman JJ; Benson AD; Cataldo MA; van der Kooi TII; Wilcox MH; Davies KA;
    J Hosp Infect; 2023 Jan; 131():213-220. PubMed ID: 36462673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.
    Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978
    [No Abstract]   [Full Text] [Related]  

  • 15. Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers.
    Schroeder CP; Hengel RL; Nathan RV; Ritter TE; Obi EN; Lancaster C; Van Anglen LJ; Garey KW
    Anaerobe; 2022 Oct; 77():102617. PubMed ID: 35940371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
    Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
    Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020.
    Silva A; Du T; Choi KB; Pelude L; Golding GR; Hizon R; Lee BE; Chow B; Srigley JA; Hota SS; Comeau JL; Thampi N;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):222-225. PubMed ID: 36718660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and Preventive Strategies for Clostridioides difficile Transmission to Household or Community Contacts during Transition in Healthcare Settings.
    Asgary R; Snead JA; Wahid NA; Ro V; Halim M; Stribling JC
    Emerg Infect Dis; 2021 Jul; 27(7):1776-1782. PubMed ID: 34152967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.